| Literature DB >> 22723916 |
Jan Marc Orenstein1, Stanford T Shulman, Linda M Fox, Susan C Baker, Masato Takahashi, Tricia R Bhatti, Pierre A Russo, Gary W Mierau, Jean Pierre de Chadarévian, Elizabeth J Perlman, Cynthia Trevenen, Alexandre T Rotta, Mitra B Kalelkar, Anne H Rowley.
Abstract
BACKGROUND: Kawasaki disease is recognized as the most common cause of acquired heart disease in children in the developed world. Clinical, epidemiologic, and pathologic evidence supports an infectious agent, likely entering through the lung. Pathologic studies proposing an acute coronary arteritis followed by healing fail to account for the complex vasculopathy and clinical course. METHODOLOGY/PRINCIPALEntities:
Mesh:
Year: 2012 PMID: 22723916 PMCID: PMC3377625 DOI: 10.1371/journal.pone.0038998
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic and clinical data on Kawasaki Disease patients in this study.
| Case | Age | Time since onset (yr of specimen) | Sex | Ethnicity | KD Therapy | Specimen |
| 1 | 3 yr | 10 days (1970s) | U | Japanese | None | Autopsy-CA |
| 2 | 10 yr | 13 days (1994) | M | Caucasian | IVIG, A, W | Autopsy-CA |
| 3 | 3 yr | 2 wks (1995) | M | Caucasian | IVIG, A | Transplant |
| 4 | 11 mo | 2.5 wks (1997) | M | Caucasian | None | Autopsy |
| 5 | 22 mo | 2.5 wk (1976) | M | Caucasian | None | Autopsy |
| 6 | 3 mo | 2.5 wk (1974) | F | Caucasian | None | Autopsy-CA |
| 7 | 4 mo | 3 wk (2000) | M | Caucasian | IVIG, A | Autopsy |
| 8 | 8 mo | 3 wk (1995) | F | U | None | Autopsy |
| 9 | 21 mo | 3 wk (1985) | F | U | A, D, H | Autopsy |
| 10 | 7 mo | 3.5 wk (1978) | F | Caucasian | None | Autopsy |
| 11 | 3.5 mo | 3–4 wk (2006) | M | Caucasian | IVIG, A, S | Autopsy-TEM |
| 12 | 4 mo | 3–4 wk (1971) | M | Caucasian | None | Autopsy-CA |
| 13 | 4.5 mo | 4 wk (2008) | M | Hispanic | IVIG, A, I, S, H,W | Autopsy-TEM |
| 14 | 4 mo | 4 wk (1997) | M | Hispanic | None | Autopsy |
| 15 | 7 mo | 4 wk (1982) | F | Caucasian | None | Autopsy |
| 16 | 10 mo | 4 wk (1984) | F | AA | A, D | Autopsy |
| 17 | 6 mo | 4–5 wk (1974) | M | Caucasian | S | Autopsy |
| 18 | 4 mo | 5 wk (2005) | M | U | IVIG, A, S, H, W | Autopsy-CA |
| 19 | 2 mo | 5 wk (2001) | M | Caucasian | IVIG,A,S,H, ECMO | Autopsy |
| 20 | 3.5 mo | 6 wk (2002) | M | Japanese-American | None | Autopsy-CA |
| 21 | 4 mo | 6 wk (1986) | F | Caucasian | A, H | Autopsy |
| 22 | 6 mo | 6.5 wk (1997) | M | Asian | IVIG, A, S, C, D, H, W,T | Autopsy |
| 23 | 4 mo | 2 mo (1999) | F | Caucasian | IVIG, A, S, M, H | Autopsy |
| 24 | 6 mo | 3 mo (1993) | M | Caucasian | IVIG, A | Transplant |
| 25 | 2 yr | 4.5 mo (2009) | F | Greek | IVIG, A | Autopsy-CA |
| 26 | 6 yr | 5 mo (2008) | M | Caucasian | None | Transplant-TEM |
| 27 | 5 yr | 7.5 mo (2008) | F | Caucasian | IVIG, A, I, prolonged S | Autopsy-TEM |
| 28 | 19 mo | 10 mo (1998) | M | AA | None | Autopsy |
| 29 | 5 yr | 1 yr (2000) | M | Caucasian | None | Autopsy |
| 30A | 19 mo | 15 mo (1994) | F | Caucasian | IVIG, A | Transplant 1-TEM |
| 30B | 12 yr | 11.5 yr (2005) | Transplant 2 | |||
| 30C | 16 yr | 14 yr (2007) | Transplant 3-TEM | |||
| 31 | 8 yr | 16 mo (1993) | F | Asian-American | IVIG, A | Thoracic autopsy |
| 32 | 2 yr | 18 mo (1999) | M | Caucasian | A, W | Transplant-TEM |
| 33 | 3 yr | 2 yr (2000) | M | U | U | Transplant |
| 34 | 19 yr | 16 yr (2008) | M | Hispanic | None | CA excision-TEM |
| 35 | 22 yr | 19 yr | F | Hispanic | A | Autopsy |
| 36 | 13 wk | U (1972) | F | Caucasian | U | Autopsy |
| 37 | 14 mo | U (2002) | M | U | U | Transplant |
| 38 | 17 mo | U (1997) | M | U | U | Transplant |
| 39 | 11 yr | U (1999) | M | Caucasian | IVIG, A | Autopsy |
| 40 | 11 mo | U (1954) | F | Caucasian | None | Autopsy |
| 41 | 7 mo | U (1959) | F | Caucasian | None | Autopsy |
CA=coronary arteries, TEM=transmission electron microscopy, IVIG=intravenous gammaglobulin, A=aspirin, AA=African-American, U=unknown, S=methylprednisolone/steroid, W=warfarin, H=heparin, D=dipyridamole, I=infliximab, ECMO=extracorporeal membrane oxygenation, C=cyclophosphamide, M=methotrexate, T=tissue plasminogen activator.
Pathologic findings in patients with Kawasaki Disease.
| Case | Time since onset | Cause of death/TX | CA pathology | Non-CA pathology | Myocardium | Comments |
| 1 | 10 days | Myocarditis | SA/C-LMP | N/A | “Eosinophilic myocarditis”, marked edema, no necrosis or PMNL | Several slides from one block |
| 2 | 13 days | Ruptured LAD CAA | Waning necrotizing arteritis, thrombosed. SA/C-LMP LAD | Intra-renal SA/C | Gallbladder hydrops | |
| 3 | 2 wks | Ruptured LCAA, TX | CABG & over-sewn hole, no SA/C- LMP visible | N/A | Acute hemorrhagic MI, PMNL. MI subacute, GT | Free wall atrophy |
| 4 | 2.5 wk | Ruptured giant LAD CAA | Giant CAA LAD, x2 RCA. SA/C-LMP | N/A | Large acute MI, no PMNL | Acute pancreatitis and splenitis |
| 5 | 2.5 wk | Ruptured left main CAA | RCAA thrombosed. SA/C-LMP | SA/C testicular artery | Acute MI, PMNL | Severe acute pancreatitis, adrenal medullary calcification, thymic atrophy |
| 6 | 2.5 wk | MI | CAA RCA, LAD, thrombosed. SA/C-LMP LAD occluded | By report: SA/C-LMP, renal, peri-esophageal, mesenteric, peri-uterine, ovarian, peri-adrenal | Subacute MI, GT | One slide |
| 7 | 3 wk | MI | Thrombosed CAA. SA/C-LMP | SA/C-LMP aortic, testicular | Acute MI, no PMNL or necrosis | Marked pericarditis, thymic necrosis, acute splenitis, TV valvulitis |
| 8 | 3 wk | Ruptured CAA | CAA, fresh & organizing thrombi, calcified. SA/C-LMP | N/A | Edema, atrophy | Mild peri-ductal chronic pancreatitis. Few sections |
| 9 | 3 wk | Ruptured giant LAD CAA | Fresh thrombi, LAD, LCx, RCAA | SA/C-LMP, iliacs. | Acute MI, PMNL | CAAs, long, sausage-shaped |
| 10 | 3.5 wk | MI | RCAA fresh thrombus. LCA SA/C-LMP | SA/C-LMP, acute renal thrombosis | Pseudo-myocarditis | Thymic calcification, renal infarct |
| 11 | 3–4 wk | Thrombosed mesenteric aneurysm, organizing, recanalized, SI infarct | Aneurysms, CAAs. Fresh thrombus RCAA. Severe SA/C-LMP | Thrombosed aneurysms, inter-costal, femoral, axillary, splenic. SA/C-LMP, hepatic, skin aortic, adrenal, renal, thymus. Ilial artery thrombosed, organizing, recanalizing | Extensive MI, PMNL, necrosis. | SA/C-LMP veins, Renal, adrenal infarcts, terminal ileum necrosis |
| 12 | 3–4 wk | MI | CAAs fresh & organizing calcified thrombi. Long dilated thrombosed CAs with SA/C-LMP to 95% | N/A | Extensive subacute MI, GT. Propagating acute necrosis, no PMNL | |
| 13 | 4 wk | Ruptured RCIAA | Multiple CAA, SA/C-LMP CAs | SA/C-LMP hepatic, renal, illiacs prostatic. Aneurysms CIAs, axillary | Mild interstitial fibrosis. No acute ischemia | Five distal aortic aneurysms up to 8 mm |
| 14 | 4 wks | MI | CAAs, LAD, LCx thrombosed. SA/C-LMP, severe | Aortitis | Focal subacute MIs, GT | Viral-type pneumonia, heart failure |
| 15 | 4 wk | Massive MI | CAA, LAD, RCA, thrombosed. SA/C, no LMP | SA/C-LMP cystic duct artery | Acute MI, PMNL. Mural thrombi. Mitral insufficiency | Gallbladder hydrops, chronic pancreatitis, central liver necrosis |
| 16 | 4 wk | MI | CAAs, RCA, LCA, LAD, LCx, thrombosed | SA/C-LMP marked, all organs, stenotic with thrombi, aortitis | MI subacute, GT. Interstitial SA/C | Concurrent group B Salmonella sepsis. Most CAA and non-CA disease seen in our cases |
| 17 | 4–5 wk | MI | CAAs, LAD, LCX, RCA, large fresh thrombi, SA/C-LMP | SA/C-LMP, epididymis, pancreas | Massive acute MI, odd-shaped, not confluent, no PMNL | Cholangitis, pericarditis, thymic involution |
| 18 | 5 wk | MI | Acute thrombosis LCxCAA, RCAA, SA/C-LMP | N/A | Acute ischemia, no PMNL | Vavulitis |
| 19 | 5 wk | MIs | Giant LAD CAA, fresh & organizing thrombi, calcified, recanalized, RCAA, SA/C-LMP, severe | SA/C-LMP, mesenteric, organizing thrombus. Mild LMP PA, IVC | Extensive non-confluent SA and healing MIs, calcifying | “Atypical myocytic process”. Generalized calcification, pigmented macrophages. Rt carotid thrombosis, collapse, S/P ECMO |
| 20 | 6 wk | MI | CAA, fresh, organizing & organized thrombi | By report: Thrombosed inter-costal aneurysms. Thickened iliacs and aortic bifurcation | Acute ischemia, no PMNL | Five sections from one CA only |
| 21 | 6 wk | MI | RCAA fresh thrombus. SA/C-LMP LAD & LtCx, organized thrombi | SA/C-LMP & thrombi, renal, pancreatic, mesenteric, muscle, iliac, hepatic | N/A | Acute renal, splenic infarcts. |
| 22 | 6.5 wk | MI | CAA, fresh, organizing, organized thrombi, calcified | SA/C-LMP, SMA. LMP subclavian | Healing MI, GT, acute propagation, no PMNL | Necrotic adrenal medullae with macs. Cholangitis, sialadenitis, chronic enteritis. Splenic collections of macrophages |
| 23 | 2 mo | MI | CAA, RCA, LAD, fresh, calcified, organizing thrombi, calcified | SA/C-LMP, renal, femoral, mesenteric, splenic | Acute MI, no PMNL. Sub-acute MI, GT | Renal, splenic infarcts. Hemorrhagic peritonitis |
| 24 | 3 mo | MI; TX | CAAs, organizing, organized calcified thrombi. RCAA, long fresh thrombus. Focal SA/C-LMP | N/A | Acute MI, no PMNLs. Healed MI | TV valvulitis |
| 25 | 4.5 mo | MI | CAA & SA/C-LMP | N/A | MI, minimal necrosis, no PMNL | |
| 26 | 5 mo | MI;TX | RCAA no thrombi. Marked SA/C-LMP | N/A | Focal ischemia, no PMNL | Minimal epicarditis |
| 27 | 7.5 mo | MI | Multiple CAA, no thrombi. Marked SA/C-LMP RCA, LCx, LAD, 90–100% stenosed | SA/C-LMP, pancreatic, splenic, renal, aortitis, uterine, >90% stenotic, paratracheal occluded | Acute necrosis, foci of PMNL. Calcified myocytes | Mild cerebral vessel lymphocyte infiltrate |
| 28 | 10 mo | MI | SA/C-LMP to 95% stenotic, one fresh thrombus | SA/C-LMP, PA, aortitis with intimal multinucleated macrophages | Acute necrosis, PMNL. Interstitial fibrosis. Myocyte calcification | Valvulitis, PV, MV, TV. Pulmonary emboli |
| 29 | 1 yr | MI | Giant CAA, organizing thrombus. SA/C-LMP LAD, 4 cm dilation | SA/C-LMP, renal, SI, adrenal, LN, hepatic, sklt muscle, PA, thyroid, stomach | Acute necrosis, mild PMNL. Rare foci of healing ischemia, GT | |
| 30A | 15 mo | MI; TX1 | RCAA fresh & organized thrombus. LCAA organizing thrombus, calcified. SA/C-LMP | N/A | Acute ischemia, no PMNL | Hypertrophied, box-car nuclei |
| 30B | 11.5 yr | MI; TX2 | CAs to 90% luminal stenosis | N/A | Massive necrosis, no PMNL. Mild fibrosis | Mild medial, IEL damage, IEL reduplicated. Rare intimal foamy macs, SA/C, prominent lymphocyte collections |
| 30C | 14 yr | CA insufficiency; TX3 | Luminal occlusion LAD, RCA, LCx CA. Intimal foamy macs, SMC. Mast cells | N/A | No acute or chronic ischemia. Lymphocytic pseudo-myocarditis | SA/C-LMP veins. Preserved CA media, IEL |
| 31 | 16 mo | MI | Lt main CAA thrombosed. SA/C-LMP, LCx, LAD, RCA | N/A | Mild ischemia, no PMNL. Healed foci of ischemia | Thorax only |
| 32 | 18 mo | Chronic ischemia; TX | RCAA. SA/C-LMP, no thrombi | N/A | Massive scarring. No inflammation, acute ischemia | |
| 33 | 2 yr | MI; TX | Lt main CAA, fresh & organizing thrombi, calcified | SA/C-LMP, variable stenosis | Large subacute MI, GT. Trapped coagulation necrosis, no PMNL | “Atypical myocytic process” |
| 34 | 16 yr | Incidental finding during cardiac catheterization for WPW; aneurysm resected | RCAA. SA/C-LMP | N/A | N/A | IMA graft |
| 35 | 19 yr | MI | SA/C-LMP to 80% stenotic | N/A | Acute MI with PMNL | |
| 36 | U | MI | Thrombosed CAA | No SA/C-LMP | Mild necrosis, PMNL Atrophy | SA/C, necrosis of MV. Limited slides |
| 37 | U | MI; TX | LADCAA, fresh thrombus. SA/C-LMP thrombi, organized, re-canalized, calcified | N/A | Healing and near-healed MI. Small acute MI, no PMNL | Prominent, generalized eosinophils |
| 38 | U | MI | Giant CAA LAD, fresh & organizing, thrombi, re-canalized, calcified. RCAA. SA/C-LMP to 90% stenosis | N/A | Massive acute necrosis, no PMNL. Large healing LV scars with elastosis | Reduplication of LCx IEL |
| 39 | U | MI | RCAA, long fresh thrombus, CAA thrombus, organized, calcified | N/A | Necrosis, no PMNL. Healed MI | TV valvulitis |
| 40 | U | MI | CAAs, fresh thrombi | By report: SA/C-LMP, hepatic, spermatic, retro-peritoneal | Hyper-eosinophilia, pseudo-myocarditis | By report: necrosis, thrombosis of choroid plexus, corpus striatum, calcified. Only heart slides |
| 41 | U | MI | Giant CAAs, fresh & organizing thrombi, calcified. SA/C-LMP | By report: SA/C-LMP, pancreatic, mesenteric, renal, peri-aortic, splenic, skeletal muscle | No acute changes. Stellate healing MIs, GT | Only heart slides |
RCIA=right common iliac artery, SA/C=subacute/chronic inflammation, CA=coronary artery, CAA=coronary artery aneurysm, LMP=luminal myofibroblastic proliferation, MI=myocardial infarction, TX=transplant, Mac=macrophage, SI=small intestine, RCA=right coronary artery, LAD=left anterior descending artery, LCx=left circumflex artery, IMA=inferior mesenteric artery, GB=gallbladder, MV=mitral valve, TV=tricuspid valve, PV=pulmonary valve, GT=granulation tissue, eos=eosinophils, SMA=superior mesenteric artery, PA=pulmonary arteries, macs=macrophages, PMNL=predominantly neutrophils, U=unknown, N/A=not available, EFE=endocardial fibroelastosis, ECMO=extracorporeal membrane oxygenation, IVC=inferior vena cava. Notes: CA sections usually contained myocardium, epicardium, and some endocardium. All patients had active SA/C plus LMP in coronary and also in available non-coronary arteries. Varying degrees of chronic hypoxia (hydropic change) seen in all cases. Anitschkow cells always seen, if case had at least two sections of myocardium. EFE always seen, if specimens included more than focal endocardium. By report=slides not available, but description sufficient to derive pathology.
Figure 2Necrotizing Arteritis (NA) and severe SA/C pan-arteritis.
A. Portion of a CA undergoing NA. The friable fragmenting wall is a mixture of neutrophils and debris. The adventitia is virtually obscured by inflammation and RBCs. H&E, case 2, original magnification 16×. B. Higher magnification of an area of CA NA predominantly of neutrophils. H&E, case 2, original magnification 63×. C. The necrotizing process has reached into the adventitia, which is only mildly inflamed. H&E, case 2, original magnification 16×. D. An area of CAA consistent with having undergone severe SA/C pan-arteritis, leaving only adventitia rich in SA/C inflammatory cells, almost exclusively small lymphocytes. Note the longitudinally sectioned vessel and fibrin/RBC lining the luminal surface. H&E, case 11, original magnification 40×. L=lumen, ADV=adventitia, V=vessel, F=fibrin, NA=necrotizing arteritis, N=neutrophils.
Figure 3Kawasaki Disease Vasculopathy, Process 2: Subacute/Chronic (SA/C) Vasculitis.
A ubiquitous, asynchronous inflammatory process that can begin as early as the first two weeks, and targets medium-sized muscular and elastic arteries. Inflammatory cells: small lymphocytes>>eosinophils & plasma cells>> macrophages. Minimal (subclinical) involvement of veins, pulmonary arteries, & aorta. Triggers Process 3, luminal myofibroblastic proliferation (LMP).
Figure 4Kawasaki Disease Vasculopathy, Process 3: Luminal Myofibroblastic Proliferation (LMP).
A process triggered locally and apparently remotely by Process 2 that can progress to total occlusion. LMP myofibroblasts are ultrastructurally, but not functionally, similar to wound healing myofibroblasts.
Figure 5Subacute/Chronic (SA/C) Inflammation in KD CAA.
A. SA/C inflammatory cells extending from the adventitia of a CA has almost reached the IEL. The EEL and most of the media are obscured/destroyed by the SA/C. The lumen contains a mixture of RBC, fibrin, and lysing leukocytes, that could indicate the beginning of a clot. H&E, case 11, original magnification 40×. B. The CA adventitia and media are rich in SA/C inflammatory cells. The thick inflammation of SA/C-LMP has obscured most of the myofibroblasts. There is more collagen staining (blue) in the adventitia than protein staining of the ECM of the SA/C-LMP. Note the increase in cellular concentration toward the lumen. Trichrome stain, case 18, original magnification 16×. C. The alpha-SMA stains SMC and vessels in this CA adventitia, SMC in the media, and MF in the SA/C-LMP. Focal areas of IEL remain. Alpha-smooth muscle actin (SMA) immunohistochemistry (IHC), case 18, original magnification 10×. D. At higher magnification, SMCs appear to be entering the media from the adventitia, while large myofibroblasts exit the luminal side into the SA/C-LMP. SA/C inflammation is present in all three layers. Alpha-SMA IHC, case 18, original magnification 63×. M=media, SMC=smooth muscle cells, MF=myofibroblast, ADV=adventitia, IEL=internal elastic lamina, LMP=luminal myofibroblastic proliferation, L=lumen, V=vessel, P=pericardium.
Figure 6Luminal Myofibroblastic Proliferation (LMP) in KD CAA.
A. The peri-luminal portion of the CA SA/C-LMP is rich in polygonal shaped myofibroblasts, while elsewhere the myofibroblasts are more pleomorphic. The background is mostly small lymphocytes. Alpha-SMA IHC, case 18, original magnification 63×. B. At higher magnification, the myofibroblasts in this area of SA/C-LMP resemble a culture of pleomorphic mesenchymal cells. The SA/C background is especially rich in small lymphocytes. Alpha-SMA IHC, case 13, original magnification 100×. C. The LMP resembles a “syncytium” of pleomorphic MF with red-staining actin and blue-staining pro-collagen. SA/C nuclei stain dark red. There is some blue staining of the ECM. The luminal lining (top) consists of RBCs and dark red staining fibrin. Trichrome stain, case 13, original magnification 100×. D. The SA/C-LMP contains large, pleomorphic myofibroblasts with large nuclei and several small nucleoli. The ECM is difficult to delineate. Trichrome stained plastic section, case 13, original magnification 160×. L=lumen, MF=myofibroblast, LMP=luminal myofibroblastic proliferation.
Figure 7SA/C-Luminal Myofibroblastic Proliferation (LMP) causes narrowing of CA in KD patients.
A. A tear drop-shaped CA with SA/C-LMP is about 50% narrowed. The actin-rich myofibroblasts and medial and adventitial SMCs stain brown. The residual media is variably thinned. Alpha-SMA IHC, case 11, original magnification 10×. B. Oval-shaped SA/C-LMP CA is virtually occluded. The MF and medial SMC stain red and there is a relatively little ECM (blue) in the LMP. Except for some thinning, the media is almost completely intact. The adventitia is densely collagenized. Trichrome stain, case 28, original magnification 10×. C. The SA/C-LMP in this elongated CA is eccentric having started at the end (top) where the media and IEL had been destroyed and progressed toward the end, which still contains media and IEL (bottom). H&E, case 26, original magnification 10×. D. An oval CA is occluded by SA/C-LMP, of relatively low SA/C cellularity concentrated around the lumen. There are several small areas of minimally preserved media. No media is present on the side with the hyper-vascular adventitia, where the process likely began. H&E, case 27, original magnification 10×. E. The SA/C-LMP progressed from the inflamed/damaged end (bottom) of this tangentially-sectioned renal artery almost reaching the opposite end (top), where the lumen is visible and there is intact media and IEL are intact. H&E, case 27, original magnification 10×. L=lumen, M=media, ADV=adventitia, LMP=luminal myofibroblastic proliferation, RBC=red blood cells, IEL=internal elastic lamina, V=vein, I=inflammation, T=renal tubules, P=pericardium, My=myocardium.
Figure 8Thrombi in coronary artery aneurysms (CAA) of KD patients.
A. A CA already severely compromised by SA/C-LMP is virtually occluded by a superimposed fresh thrombus (dark red) that blends into the SA/C-LMP. Trichrome stain, case 18, original magnification 16×. B. Part of a NA CAA occluded by a fresh thrombus. There is a small area of organizing thrombus. Since only mildly inflamed fibrotic adventitia remains, it is not possible in this section to distinguish between NA and SA/C as the etiology. H&E, case 11, original magnification 10×. C. A small portion of CAA thrombus. The vascular granulation tissue has a loose matrix containing few free RBC, spindle cells and mononuclear cells, a few of which are macrophages containing brown hemosiderin blood pigment. Spindle cells are reaching into the luminal RBCs. H&E, case 22, original magnification 63×. D. The oldest peripheral thrombus in this CAA is re-canalizing. There are superimposed fresher thrombi. Since the CAA still has some remaining media, the aneurysm likely resulted from severe SA/C pan-arteritis. H&E, case 37, original magnification 10×. E. This organized SA/C CAA thrombus has peripheral clumps of calcium. Some of the media is still visible (upper right). H&E, case 19, original magnification 16×. L=lumen, LMP=luminal myofibroblastic proliferation, M=media, ADV=adventitia, ORG=organizing thrombi, R=recanalized, Ca=calcium, V=vessel.
Figure 9Myocarditis.
A. Low magnification H&E of a poorly-preserved hourglass-shaped epicardial CA showing varying degrees of SA/C peri-arteritis, transmural SA/C, and minimal preserved media. H&E, case 1, original magnification 10×. B. Perivascular and transmural SA/C inflamed adventitia and heavily damaged media with some discernible SMC and IEL, and SA/C-LMP with scattered pleomorphic myofibroblasts. There are some eosinophils intermixed with the small lymphocytes. H&E, case 1, original magnification 16×. C. A higher magnification of a typical area of SA/C-LMP with prominent amphophilic myofibroblasts in a background of mostly small lymphocytes, scattered eosinophils, and likely macrophages in a fibrillar ECM that shows some artifactual spaces. H&E, case 1, original magnification 25×. D. A typical area of the highly edematous interstitial myocarditis especially rich in eosinophils, with scattered lymphocytes, macrophages, and plasma cells. Note the longitudinally-sectioned caterpillar-shaped and cross-sectioned, owl eye-shaped (unidentified) Anitschkow chromatin pattern in a myocyte and two unidentified cell nuclei, respectively. H&E, case 1, original magnification 40×. L=lumen, NV=nerve, IEL=internal elastic lamina, Eo=eosinophil, AM=Anitschkow myocyte, MF=myofibroblast, V=vein, ADV=adventitia, M=media.
Figure 10Early transitional changes of medial SMC into myofibroblasts.
A) Tangential section of media showing variably oriented electron dense banded collagen (e.g., C). The SMC are somewhat swollen, yet the actin (A)/dense bodies (long red arrows) are still apparent. The external lamina is obscured by the ECM. The dense plaques (short black arrows) are visible. Case 32, original magnification 5,000×. B) Longitudinal section of medial SMCs commencing their transition to MF. There is abundant actin (A) with dense bodies (long red arrows), dense plaques (short black arrows), shedding external lamina (short red arrows), and serrated nuclei. Electron dense banded collagen production has increased, and there is fibronectin (long black arrows). Higher magnification showed abundant pinocytic vesicles. Case 32, original magnification 4,000×.
Figure 11Increase in myofibroblast RER and pleomorphism, as well as intercellular elastin.
A) The actin (A)/dense bodies (long red arrows) share the cytoplasm with RER. The extracellular matrix is composed almost exclusively of haphazardly arranged electron dense banded collagen. The ECM obscures the dense plaques and external lamina. Pinocytic vesicles (P) are visible. Case 32, original magnification 5,000×. B) Dense plaques (short black arrows), actin (A), and dense bodies (long red arrows) have decreased and there is more RER. Note the abundant electron dense intercellular elastin (E), mixed with the collagen. Note the external lamina (long black arrows). Case 32, original magnification 5,000×.
Figure 12Myofibroblast fibronectin, shed external lamina, and intercellular junction.
A) There is copious actin (A) with prominent dense bodies (long red arrows) in this large pleomorphic myofibroblast. The nucleus is also large and irregular. Note the electron dense fibronectin (long black arrows). The ECM is loose and contains shed external lamina (short red arrows). Case 32, original magnification 5,000×. B) The cell has two prominent visible cytoplasmic extensions and is shedding strips of external lamina (short red arrows) into a loose stroma of granular-fibrillar ECM, with no banded collagen. Dense bodies (long red arrow), actin (A) and RER are present within the cell. Case 26, original magnification 5,000×. Inset: A non-specific junction (JXT) joins two MF. Actin (A) is present with very prominent dense bodies (long red arrows). Case 13, original magnification 10,000×.
Figure 13Copious cytoplasmic RER and shed external lamina and fibronectin.
A) The slightly tangentially sectioned cell has about equal RER and actin (A) with dense bodies (long red arrows). There is a single large primary lysosome (*), shed external lamina (short red arrows), and relatively sparse dense plaques (short black arrows). Case 13, original magnification 5,000×. B) A MF with more RER than peripheral actin (A)/dense bodies (long red arrows). The nucleus is large and irregular with a prominent nucleolus and apparently lost some chromatin during processing. Shed external lamina (short red arrow) and fibronectin (long black arrow) are prominent. Case 13, original magnification 4,000×.
Figure 14Pleomorphic mono- and binucleated myofibroblasts, abundant RER and SA/C lymphocytes.
A) RER dominates the cytoplasm of this stellate myofibroblast with a complex nucleus and at least two small nucleoli; some actin (A) is present. The matrix contains some shed external lamina (short red arrows) and fine filamentous collagen. There are typical small lymphocytes (L) with high nuclear to cytoplasmic ratios. Case 13, original magnification 1,700×. B) This MF is bi-nucleated and has very dilated, complicated profiles of RER plus actin (A). The loose ECM is dominated by shed external lamina (short red arrows). Case 26, original magnification 5,000×.
Figure 15Explanted heart (transplant 2) with post-transplant CA vasculopathy showing similar features to those in KD LMP.
In patient 30, the second transplanted heart was removed because of post-transplant vasculopathy; pathologic myofibroblasts were observed in the luminal lesions of the coronary arteries. This myofibroblast is similar to the one in Figure 10B with its broad irregular processes (right field). It has extensive dense plaques (short black arrows), abundant actin (A) and some dense bodies (long red arrows). External lamina is both attached and shed (short red arrows). The loose banded collagen (C) is in the upper left of the field. Case 30C, original magnification 4,000×.
Newly described pathologic features observed in the 41 KD patients.
|
|
| NA involves medium sized muscular and elastic arteries but not veins, pulmonary arteries, and apparently not the aorta. |
| Severe |
| The intra-luminal stenosing lesions caused by |
| LMP can also occur in areas remote from active SA/C inflammation, possibly due to circulating factors. |
| SA/C-LMP lesions do not undergo organization or re-canalization nor represent granulation/scar tissue. |
| Transformation of medial SMC into myofibroblasts has been hypothesized but it required the TEM performed in this study to be confirmed. |
| Adventitial SMC can apparently replace medial SMC and can also transform directly into myofibroblasts, when medial SMC are lacking. |
| SA/C and SA/C-LMP also involves veins, pulmonary arteries, and the aorta, but apparently only to a relatively mild, subclinical degree. |
| SA/C inflammatory cells are predominantly small lymphocytes accompanied by varying numbers of eosinophils and plasma cells, while macrophages, mast cells, and neutrophils are rare. |
| The majority of lesional macrophages are apparently recruited to areas of medial and adventitial SA/C damage, where they scavenge debris and then migrate to draining lymph nodes. |
| There appears to be no consistent pattern to the location, abundance, and extent of fusiform dilations, saccular aneurysms, and stenosing SA/C-LMP lesions among cases. |
| Calcification occurs within organizing and organized thrombi, but not in the remaining tissue/wall of CAA. |
| Infarcts of the kidneys, spleen, and adrenals due to SA/C-LMP are relatively common, but were apparently not clinically evident at the time of death/transplant. |
| KD patients can have an interstitial “eosinophilic-type” myocarditis accompanied by profound edema and interstitial lymphocytes, but without myocyte degeneration or necrosis. |
| Pseudo-myocarditis, from SA/C inflammation directly extending from CA pan-arteritis, is relatively common and can be misinterpreted as true myocarditis. |
| SA/C endocarditis appears to be a virtually universal phenomenon that can seriously involve the contiguous valves. The fibrotic endocardium frequently undergoes elastosis consistent with endocardial fibroelastosis. |
| Pericarditis varies in the degree of SA/C inflammation, which is usually most concentrated over inflamed CA. |
| Stenosing LMP with little to no SA/C inflammation and intact elastic laminae and media can occur at “remote” arterial sites, suggesting that factors from active SA/C inflammation can circulate and act widely. |
| Patterns of myocardial ischemia/infarction can be strikingly complex. |
| Patients appear capable of surviving surprisingly extensive myocardial scarring. |
| A spectrum of microscopic SA/C and lymphocyte/macrophage aortitis can be seen. |
| Eosinophilic and giant cell-like myocarditis may be associated with KD. |
| KD clinicopathology develops in roughly two phases: acute NA (likely the direct effect of a virus) and SA/C inflammation causing SA/C-LMP stenosis (likely immune-mediated). |
Pathologic observations that differ from those previously reported.
| Neither granulomatous inflammation nor granulomas were detected. |
| Severe CAA do not “regress”, “resolve”, or “remodel”, but rather they thrombose. |
| Neutrophils characterize NA, while lymphocytes, plasma cells, and eosinophils characterize SA/C inflammation. |
| Small vessel pathology is rare and mild, and involves intra-myocardial and intra-renal arteries. |
| There was no medial SMC hyperplasia. |
| There was minimal medial fibrosis/scarring. |
| There were no histologic features of atherosclerosis even in remote deaths or transplants. |
Potential clinicopathologic outcomes following infection with the KD etiologic agent.
| If the child lacks the “required” genetics, the ubiquitous seasonal infection will likely be essentially inconsequential, i.e., just another mild respiratory illness of childhood. In some of these individuals it may lead to ciliated bronchial cell intracytoplasmic inclusions. Whether these children harbor the putative KD agent for a prolonged period in an immunologically controlled/suppressed state is unknown. |
| Some genetically predisposed children may develop some or all of the characteristic clinical signs and symptoms of KD, but no overt vasculitis. |
| Other predisposed children may develop the clinical features of KD with inconsequential CA vasculitis. |
| Others may develop CA or NCA fusiform dilations with or without aneurysms that neither rupture nor thrombose, and develop asymptomatic SA/C and SA/C-LMP, which may progress slowly until clinically significant |
| At about 3–4 weeks, a very small percentage of IVIG-untreated or resistant patients die from CAA and myocardial ischemia, ruptured CA or NCA aneurysm, or thrombosis of a NCA ( |
| Patients who do not die from an “acute” event can experience progressive LMP stenosis until they ultimately die from coronary insufficiency (Cases 25 at 4.5 months and 27 at 7.5 months) or receive a cardiac transplant (Cases 30 at 15 months, 32 at 18 months, and 33 at 2 years); the complicated, unpredictable nature of SA/C-LMP lesions makes coronary artery bypass grafting potentially difficult and angioplasty of variable benefit. |
| “Stable” CAA may eventually accumulate enough thrombotic material to eventually cause critical myocardial ischemia. |
Clinical implications of this study.
| IVIG treatment is likely to abrogate NA pathology and thus affect subsequent events, so early therapy is likely critical. |
| Since the threat of new and the extension of previous CA thrombi persists, more aggressive and prolonged anti-platelet and anti-thrombotic therapies for patients with significant CA abnormalities may be warranted. |
| A study of prolonged anti-inflammatory therapy in patients with CA abnormalities should be considered, since persistent inflammation is a feature of SA/C and SA/C-LMP. |
| Identification of therapies that interfere with the transition of SMC to myofibroblasts and progression of SA/C-LMP and LMP lesions is urgent. |
| Luminal narrowing from CAA thrombosis followed by calcification of organizing thrombi should aid with pathologic/radiographic interpretation. |
| Apparently “regressed” fusiform dilations are still capable of undergoing luminal narrowing by persistent SA/C and SA/C-LMP. |
| Endocarditis appears to be very common and can potentially cause serious valvular disease. |
| Endocarditis often leads to endocardial fibroelastosis, which may have a restrictive cardiac effect and requires monitoring. |
| Long-term survivors with significant NCA pathology may ultimately suffer some pancreatic, renal, or adrenal dysfunction. |
| KD vasculopathy does not appear to progress to atherosclerotic coronary artery disease. |